Sanara Medtech Inc (SMTI)
Healthcare
Medical Instruments & Supplies
33.90 $
-0.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Sanara Medtech Inc (SMTI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 40.8% of the shares are freely tradable; institutional investors hold 16.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
16.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
53.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
40.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
9Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 2.50 | 228,767 | +7.0 | 03/31/2026 |
| Vanguard Group Inc | 2.00 | 183,137 | +0.6 | 12/31/2025 |
| Vanguard Capital Management, LLC | 1.65 | 151,367 | +0.0 | 03/31/2026 |
| Stonebridge Wealth Management, LLC | 1.49 | 136,899 | +1.5 | 03/31/2026 |
| Royal Bank of Canada | 1.43 | 131,389 | +11.7 | 03/31/2026 |
| Geode Capital Management, LLC | 0.93 | 85,662 | +8.4 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 0.83 | 76,282 | +56.9 | 03/31/2026 |
| Squarepoint Ops LLC | 0.80 | 73,607 | +50.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.15 | 105,299 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 0.83 | 76,124 | +1.0 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.